[1] |
Wu M, Rementer C, Giachelli CM. Vascular calcification: anupdate on mechanisms and challenges in treatment [J]. Calcif Tissue Int, 2013, 93(4): 365-373.
|
[2] |
Mazzini MJ, Schulze PC. Proatherogenic pathways leading to vascular calcification [J]. Eur J Radiol, 2006, 57(3): 384-389.
|
[3] |
Baker R, Rogers KD, Shepherd N, et al. New relationships between breast microcalcifications and cancer [J]. Br J Cancer, 2010, 103(7): 1034-1039.
|
[4] |
Wahlgren CM, Zheng W, Saalan W. Human carotid plaque calcification and vulnerability. Relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology [J]. Cerebrovasc Dis, 2009, 27(2): 193-200.
|
[5] |
Wu B, Pei X, Li ZY. How does calcification influence plaque vulnerability?Insights from fatigue analysis [J]. Sci World J, 2014, 2014: 417324.
|
[6] |
杨绍基,任红. 传染病学 [J]. 7版. 2012: 210-218.
|
[7] |
陆再英,钟南山. 内科学 [J]. 7版. 2012: 267-302.
|
[8] |
Agharazii M, St-Louis R, Gautier-Bastien A. Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification [J]. Am J Hypertens, 2015, 28(6): 746-755.
|
[9] |
Bessueille L, Magne D. Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes [J]. Cell Mol Life Sci, 2015, 72(13): 2475-2489.
|
[10] |
Nadra I, Mason JC, Philippidis P. Proinflammatory activation of macrophages by basic calcium phosphate cryatals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification [J]. Circ Res. 2005, 96(12): 1248-1256.
|
[11] |
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?[J]. Lancet, 2001, 357: 539-545.
|
[12] |
Kuper H, Adami HO, Trichopoulos D. Infection as a major preventable cause of human cancer [J]. Intern Med, 2000, 248: 171-183.
|
[13] |
Fidler IJ. Microenvironment for treatment of cancer metastasis [J]. Nstl Cancer Inst, 1995, 87: 1588-1592.
|
[14] |
Bar EE, Lin A, Mahairaki V, et al. Hypoxia increases the expression of stem-cell markers and promotes clongenicity in glioblastoma neurospheres [J]. Am J Pathol, 2010, 177(3): 1491-1502.
|
[15] |
Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis [J]. Cell Death Differ, 2008, 15(4): 678-685.
|
[16] |
Brahimi-Horn MC, Chiche J, Pouyssegur J, Hypoxia and cancer [J]. J Mol Med, 2007, 85(12): 1301-1307.
|
[17] |
Cairns RA, Hairris IS, Mak TW. Regulation of cancer cell metabolism [J]. Nat Rev Cancer, 2011, 11(2): 85-95.
|
[18] |
Semenza GL. Involement of hypoxia-inducible factor 1 in human cancer [J]. Inter Med, 2002, 41(2): 79-83.
|
[19] |
Bensaad K, Harris AL. Hypoxia and metabolism in cancer [J]. Adr Exp Med Biol, 2014, 772: 1-39.
|
[20] |
Bhujwalla ZM, Artemov D, Ballesteros P. Combined vascular and extracellular Ph imaging of solid tumors [J]. NMR Biomed. 2002, 15(2): 114-119.
|
[21] |
Fondrinier E, Lorimier G, Guerin-Boblet V. Breast microcalcifications: multivariate analysis of radiologic and clinical factors for carcinoma [J]. World J Surg, 2002, 26(3): 290-296.
|
[22] |
Sapandowski A, Stope M, Zimmermann U, et al. Cardiolipin composition correlates with prostate cancer cell proliferation [J]. Mol Cell Biochem, 2015, 410(1-2): 175-185.
|
[23] |
Bellenghi M, Puglisi R, Pedini F, et al. SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B [J]. J Pathol, 2015, 236(3): 315-325.
|